UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 1, 2018
SIGMA LABS, INC.
(Exact Name of Registrant as Specified in Charter)
Nevada | | 001-38015 | | 27-1865814 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
|
3900 Paseo del Sol, Santa Fe, New Mexico 87507 |
(Address of Principal Executive Offices) (Zip Code) |
|
N/A |
(Former Name or Former Address, if Changed Since Last Report) |
Registrant’s telephone number, including area code:(505) 438-2576
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
1
ITEM 5.03AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.
Effective March 5, 2018, the Amended and Restated Articles of Incorporation, as amended, of Sigma Labs, Inc. (“our” or the “Company”), was amended pursuant to a Certificate of Amendment filed with the Nevada Secretary of State to increase the authorized number of shares of our common stock to 15,000,000 (the "Amendment"). A copy of the Certificate of Amendment is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference
ITEM 5.07SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
On March 1, 2018, the Company held a Special Meeting of Stockholders (the "Special Meeting") to considerand vote upon a proposal to approve the Amendment.
The foregoing proposal was approved by the Company's stockholders at the Special Meeting, with 2,887,103 "FOR" votes, 518,037 "AGAINST" votes, and 33,716 "ABSTAIN" votes. There were no broker non-votes in connection with this proposal.
ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS.
(d)Exhibits.
Exhibit Number | | Description |
3.1 | | Certificate of Amendment to Amended and Restated Articles of Incorporation, as amended, of Sigma Labs, Inc. |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
March 6, 2018 | SIGMA LABS, INC. |
| |
| |
| By:/s/ John Rice |
| Name:John Rice |
| Title:Interim Chief Executive Officer |
| |
| |
3
